{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:08:10Z","timestamp":1781046490958,"version":"3.54.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17_supplement_3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2010,4,27]]},"DOI":"10.1212\/wnl.0b013e3181dbb51c","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T15:12:39Z","timestamp":1426691559000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":103,"title":["Freedom from disease activity in multiple sclerosis"],"prefix":"10.1212","volume":"74","author":[{"given":"Eva","family":"Havrdova","sequence":"first","affiliation":[{"name":"From the Charles University in Prague (E.H.), First Faculty of Medicine, Prague, Czech Republic; University of Pennsylvania School of Medicine (S.G.), Philadelphia; Rush University Medical Center (D.S.), Chicago, IL; and San Raffaele Scientific Institute (G.C.), Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Galetta","sequence":"additional","affiliation":[{"name":"From the Charles University in Prague (E.H.), First Faculty of Medicine, Prague, Czech Republic; University of Pennsylvania School of Medicine (S.G.), Philadelphia; Rush University Medical Center (D.S.), Chicago, IL; and San Raffaele Scientific Institute (G.C.), Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Stefoski","sequence":"additional","affiliation":[{"name":"From the Charles University in Prague (E.H.), First Faculty of Medicine, Prague, Czech Republic; University of Pennsylvania School of Medicine (S.G.), Philadelphia; Rush University Medical Center (D.S.), Chicago, IL; and San Raffaele Scientific Institute (G.C.), Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[{"name":"From the Charles University in Prague (E.H.), First Faculty of Medicine, Prague, Czech Republic; University of Pennsylvania School of Medicine (S.G.), Philadelphia; Rush University Medical Center (D.S.), Chicago, IL; and San Raffaele Scientific Institute (G.C.), Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2006.052688"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115707"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380502"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.06.003"},{"key":"e_1_3_3_6_2","unstructured":"ENBREL [package insert]. Thousand Oaks CA: Amgen Inc. and Wyeth Pharmaceuticals; 2008."},{"key":"e_1_3_3_7_2","unstructured":"HUMIRA [package insert]. Chicago IL: Abbott Laboratories; 2008."},{"key":"e_1_3_3_8_2","unstructured":"REMICADE [package insert]. Malvern PA: Centocor Inc.; 2008."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90632-7"},{"key":"e_1_3_3_10_2","unstructured":"RITUXAN [package insert]. San Francisco CA: Biogen Idec Inc. and Genentech Inc.; 2008."},{"key":"e_1_3_3_11_2","unstructured":"ORENCIA [package insert]. Princeton NJ: Bristol-Myers Squibb; 2008."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.4.1314"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.08.019"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780241012"},{"key":"e_1_3_3_15_2","first-page":"1101","volume":"35","year":"1996","unstructured":"Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996;35:1101\u20131105.","journal-title":"Br J Rheumatol"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390105"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"e_1_3_3_18_2","unstructured":"United States Department of Health and Human Services Food and Drug Administration. Guidance for Industry: Clinical Development Programs for Drugs Devices and Biological Products for the Treatment of Rheumatoid Arthritis (RA) [online]. Available at: http:\/\/www.fda.gov\/cber\/gdlns\/rheumcln.htm. Accessed February 25 2009."},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","unstructured":"Ferraccioli GF Gremese E Tomietto P Favret G Damato R Di Poi E. Analysis of improvements full responses remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate cyclosporin A sulphasalazine) or monotherapy for three years. Rheumatology (Oxford) 2002;41:892\u2013898.","DOI":"10.1093\/rheumatology\/41.8.892"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20351"},{"key":"e_1_3_3_21_2","first-page":"245","volume":"12","year":"1985","unstructured":"Wolfe F, Hawley DJ. Remission in rheumatoid arthritis. J Rheumatol 1985;12:245\u2013252.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21519"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20568"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21655"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.4.655"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390304"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.7.1268"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03334-0"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.19.2161"},{"key":"e_1_3_3_30_2","unstructured":"European Medicines Agency. Rebif European Public Assessment Report: Scientific Discussion [online]. Available at: http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/Rebif\/002298en6.pdf. Accessed February 25 2009."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.64"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.4.662"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430114"},{"key":"e_1_3_3_35_2","unstructured":"Kappos L Arnason BGW Comi G et al. High proportion of patients free from disease activity in all 3 arms of the high-dose Betaferon\u00ae trial. Presented at the Annual Meeting of the European Neurological Society; June 7\u201311 2008; Nice France."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068005"},{"key":"e_1_3_3_37_2","first-page":"254","volume":"8","year":"2009","unstructured":"Havrdova E, Galetta S, Hutchinson M, et al. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol 2009 Mar;8:254\u2013260.","journal-title":"Neurol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3181dbb51c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:44:34Z","timestamp":1711532674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3181dbb51c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,27]]},"references-count":36,"journal-issue":{"issue":"17_supplement_3","published-print":{"date-parts":[[2010,4,27]]}},"alternative-id":["10.1212\/WNL.0b013e3181dbb51c"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3181dbb51c","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,27]]}}}